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Abstract
Background: The treatment of choice for severe rheumatic mitral stenosis (MS) is balloon 
mitral valvuloplasty (BMV). Assessment of MS severity is usually performed by 
echocardiography. Before performing BMV, invasive hemodynamic assessment is also 
performed. The effect of anesthesia on the invasive assessment of MS severity has not been 
studied. The purpose of the present study was to assess changes in invasive hemodynamic 
measurement of MS severity before and after induction of general anesthesia. 
Methods: The medical files of 22 patients who underwent BMV between 2014 and 2020 
were reviewed. Medical history, laboratory, echocardiographic and invasive measurements 
were collected. Anesthesia induction was performed with etomidate or propofol. Pre-
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procedural echocardiographic measurements of valve area using pressure half time, and 
continuity correlated well with invasive measurements using the Gorlin formula. 
Results: After induction of anesthesia the mean mitral valve gradient dropped by 2.4 mmHg 
(p = 0.153) and calculated mitral valve area (MVA) increased by 0.2 cm2 (p = 0.011). A wide 
variability in individual response was observed. While a drop in gradient was noted in 14 
patients, it increased in 7. Gorlin derived MVA rose in most patients but dropped in 4. 
Assuming a calculated MVA of 1.5 cm2 and below to define clinically significant MS, 4 
patients with pre-induction MVA of 1.5 cm2 or below had calculated MVA above 1.5 cm2 
after induction. 
Conclusions: The impact of general anesthesia on the hemodynamic assessment of MS is 
heterogeneous and may lead to misclassification of MS severity. 
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INTRODUCTION
Rheumatic heart disease (RHD), once the most common cause of valvular heart 
disease, is now relatively rare in the Western world. Mitral stenosis (MS), the most common 
manifestation of RHD, is still encountered in areas with migrant populations. The treatment 
of choice for rheumatic MS is balloon mitral valvuloplasty (BMV) [1]. The indications for 
valve intervention depend on the presence of compatible symptoms and objective evidence of
significant MS. The American Heart Association (AHA) and the American College of 
Cardiology (ACC) guidelines define severe MS as a mitral valve area (MVA) of 1.5 cm2 or 
less. In these cases, BMV is recommended if there are no procedural contra-indications and 
when there are favorable anatomical and clinical characteristics [2]. Diagnosis of significant 
MS depends primarily on echocardiographic assessment using trans-thoracic evaluation of 
valve gradients and area and recently three-dimensional transesophageal planimetry of the 
valve opening [3, 4]. Invasive hemodynamic assessment of mitral valve stenosis severity is 
performed routinely before BMV, however, hemodynamic changes in cardiac output and 
vascular resistance associated with anesthesia, often performed before BMV, may affect 
hemodynamic measurements of valvular stenosis severity. The purpose of the current study 
was to assess changes in invasive hemodynamic measurement of MS severity before and 
after induction of general anesthesia. 
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METHODS
Patient population and data collection
The clinical records of 22 patients who underwent anesthesia during BMV procedure 
at the Sheba Medical Center Invasive Cardiology Unit between July 2014 to March 2020 
were investigated. The research protocol was approved by our Institutional Review Board 
(5453-18-SMC). 
Baseline characteristics including age, gender, relevant medical history, New York 
Heart Association (NYHA) functional class before and after the procedure, laboratory tests, 
echocardiographic measurements before and after the procedure and invasive measurements 
were collected in a retrospective manner from the electronic patient record and documented 
in an electronic case report form. A letter of consent was sent to patients who had missing 
data and were later called in order to collect the information.  
Echocardiographic examination
Transthoracic echocardiography (TTE) was performed within 1 month prior to the 
BMV. Transvalvular gradients were assessed using Doppler flow velocity analysis after 
optimization of gain settings and beam orientation. Maximal and mean gradients were 
obtained. Valve area was evaluated by planimetry, pressure half time (PHT) and by the 
continuity equation according to the current American Society of Echocardiography (ASE) 
guidelines [5]. Transesophageal echocardiography (TEE) was performed routinely before 
anesthesia. The diagnosis of significant MS was confirmed, and the presence of intra-cardiac 
thrombus was ruled out. All procedures were guided by continuous TEE imaging. 
Hemodynamic assessment, BMV technique, and anesthesia
All patients underwent invasive hemodynamic assessment prior to induction of 
anesthesia. Pressures were recorded in the right atrium, right ventricle, pulmonary artery and 
pulmonary capillary wedge (PCW) using a 7F Swan-Ganz flotation catheter. Simultaneous 
pressures in the PCW and left ventricle (LV) were recorded to assess the trans-mitral 
gradient. Cardiac output was calculated using measured Fick (O2 consumption was measured 
with a Cosmed Fitmate PRO, Rome, Italy). Valve area was assessed using the Gorlin 
equation [6]. After a decision was made to proceed with BMV, patients underwent anesthesia 
induction and endotracheal intubation. Invasive hemodynamic assessment was repeated under
anesthesia. If no contra-indication was noted, trans-septal puncture was performed under TEE
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guidance (catheter used) and BMV was performed using Inoue Balloon technique [7]. Post-
valvuloplasty measurements were repeated after BMV. 
Anesthesia was induced using fentanyl in a dose of 1–2 µg/kg body weight and 
hypnotic drug (etomidate 0.2–0.4 mg/kg or propofol 1–2 mg/kg) and rocuronium bromide in 
a dose of 0.5 mg/kg was used to facilitate muscle relaxation before orotracheal intubation. 
Patients were ventilated in volume-controlled mode with tidal volume of 6–8 mL/kg and 
respiratory rate adjusted to achieve EtCO2 values of 30–35 mmHg. Anesthesia was 
maintained using inhaled anesthetics (isoflurane or sevoflurane) and phenylephrine was used 
to treat hypotension following the induction of anesthesia.  
Statistical analysis
Variables were described according to their properties. Categorical variables are 
reported in frequencies and percentages. These variables are included only as baseline 
descriptive data for the study population, and no statistical testing was required in this case. 
The distribution for all continuous variables was assessed using a visual histogram and the 
Shapiro-Wilk test for normality, and none of them were found to have a normal distribution. 
When testing for significant differences, these variables are shown as median (intraquartile 
range), with differences tested using the Wilcoxon signed-rank test. All statistical tests were 
2-sided, and a p value of less than 0.05 was considered significant. 
The statistical analysis was carried out with the use of R version 3.6.1 software (The 
R Foundation) and R-studio 1.2.5001 (R Studio, Inc.).
RESULTS 
The study included 22 patients who underwent hemodynamic assessment of mitral 
valve stenosis before and after induction of anesthesia. The clinical and echocardiographic 
characteristics are shown in Table 1. Mean age was 55  12 and 91% were women. They had 
no major comorbidities and most suffered from NYHA class II–III heart failure. The pre-
procedural echocardiographic assessment of mitral valve gradients and area correlated well 
with invasive measurements before anesthesia. The different echocardiographic 
measurements including PHT, planimetry and continuity were compared to the calculated 
invasive valve area using the Gorlin formula. All 3 methods derived valve areas similar to the
calculated Gorlin MVA (p = 0.7, p = 0.08, p = 0.4, respectively).
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Hemodynamic assessment before and after induction of anesthesia are shown in Table
2. After induction of anesthesia a non-significant rise in cardiac output and cardiac index and 
drop in mean and peak aortic pressures, as well as a drop in pulmonary arterial pressure were 
observed. A numerical reduction in pulmonary vascular resistance and in systemic vascular 
resistance were observed. Mean mitral valve gradient dropped by 2.4 mmHg (p = 0.15) (Fig. 
1) and calculated MVA increased by 0.2 cm2 (p = 0.01) (Fig. 2). Patient level data showing 
post-induction changes in mitral valve mean gradient are shown in Figure 3 and post-
induction changes in calculated valve area in Figure 4. As shown, there is wide variability in 
individual patient response to anesthesia induction. While a drop in gradient was observed in 
14 patients, in 7 patients the gradient actually increased. Of all patients who showed a drop in
gradient, the heart rate increased in 6 and decreased in 4. No change in heart rate was noted in
the other cases. Also, there was wide variability in the magnitude of drop in pressure and in 4 
patients a drop greater than 10 mmHg was observed. Assuming a cutoff of 10 mmHg defining
severe MS, 6 out of 17 patients with a pre-induction gradient greater or equal to 10 mmHg 
dropped below this threshold after induction. Conversely, 2 out of 5 patients with a pre-
induction gradient below 10 mmHg rose above this threshold after. Similar findings are 
shown in calculated MVA, using the Gorlin equation, after induction. While most patients 
demonstrated an increase in valve area, 4 patients actually showed a reduction in area. Again, 
there was a large variability in the magnitude of change with 5 patients demonstrating greater 
than 0.5 cm2 increase in calculated valve. Assuming a calculated MVA of 1.5 cm2 and below 
to define clinically significant MS, 4 patients with pre-induction MVA of 1.5 cm2 or below 
had calculated MVA above 1.5 cm2 after induction. However, no patients with pre-induction 
MVA above 1.5 cm2 changed category after induction. 
DISCUSSION
Herein, hemodynamic severity of MS in patients undergoing BMV under anesthesia 
was assessed. Significant variability was found when valve evaluation was performed 
immediately before and immediately after induction of anesthesia. Furthermore, variability 
occurred in both directions and has the potential to either under-estimate or over-estimate MS
severity after induction. According to available research, no previous studies have reported on
this issue. 
In the present study, pre-induction hemodynamic assessment of trans-mitral gradient 
and valve area using the Gorlin equation showed good correlation with pre-procedural TTE 
performed within 1 month prior to BMV. Previous studies have also demonstrated good 
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correlation between hemodynamic assessment using the Gorlin equation and 
echocardiographic assessment using PHT or the continuity equation [8–10]. 
Even 70 years after its formulation, the Gorlin formula is still widely considered the 
standard of reference in the assessment of valvular stenosis [6]. The formula was derived 
from 2 simplified equations describing steady state flow through an orifice. It was validated 
in 11 patients with MS and compared with valve areas estimated at valve surgery or at 
autopsy. The Gorlin formula demands 3 determinations to be made: determination of a 
constant; determination of trans-valvular gradient; and determination of cardiac output (trans-
valvular flow) [11]. Errors in determination of trans-mitral gradient and cardiac output can 
lead to inaccuracies in MVA assessment. However, it has also been shown that the constant 
used in the Gorlin formula is not constant across all hemodynamic conditions. Cannon et al. 
[12], using a wide range of flows and pressures across valves of known orifice area in a 
hemodynamically accurate pulsatile flow model, was able to show that calculated valve area 
increased with increasing flow even though the actual orifice area was constant. Segal et al. 
[13] and others [14, 15] confirmed these findings and found that the Gorlin formula may 
actually under-estimate the true orifice area, particularly in patients with low cardiac output. 
Interestingly, and in contrast to echocardiographic MVA assessment using PHT and 
continuity equation which have been shown to increase significantly with increasing heart 
rate [16, 17], the Gorlin formula has been shown to be relatively stable across a wide range of
heart rates induced by ventricular pacing [17].  
According to available research, no previous studies have assessed the effects of 
general anesthesia on the hemodynamic assessment of MS severity. While as a group the 
mean changes in trans-valvular gradient and area (Figs. 3, 4) are small, however, due to inter-
individual variability in response to anesthesia, striking changes were observed in individual 
patients. In fact, changes in gradient class were observed in 8 of 22 patients (severe to non-
severe in 6 of 17 and non-severe to severe in 2 of 5). More importantly, 4 patients with pre-
induction MVA of 1.5 cm2 or below (severe MS) had calculated MVA above 1.5 cm2 after 
induction. Induction of anesthesia and positive pressure ventilation are associated with 
changes in cardiac output, pulse rate, blood pressure and pulmonary and systemic resistance 
which can influence trans-mitral gradient and flow [18, 19]. Since the constant used in the 
Gorlin formula has been shown to be inconstant under different flow and pressure conditions,
the interplay of these factors is likely responsible for the variability observed in the 
hemodynamic assessment of MS before and after induction of anesthesia. 
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In summary, hemodynamic evaluation of MS severity before BMV under general 
anesthesia is unreliable. As stated in the current ACC guidelines [2], echocardiography is a 
reliable diagnostic modality to diagnose, follow, and decide on the timing for therapy in 
patients with MS. Additional hemodynamic assessment may be performed in cases with 
questionable symptoms for whom there is discordance between the clinical and 
echocardiographic findings. In these difficult cases, invasive hemodynamic assessment can 
add important information as the valve gradient is measured directly rather than calculated 
from Doppler flow velocity. In these cases, the assessment of MS should be performed 
preferably without any sedation to avoid influencing the hemodynamic measurements. 
Limitations of the study
This study has several limitations. It is single-center with a limited number of 
patients. The anesthetic protocol, while similar, was not uniform and thus it is impossible to 
eke out the particular influence of specific anesthetic drugs.
In addition, while in some major centers BMV is performed under conscious sedation 
with TTE monitoring, peri-procedural monitoring with TEE under general anesthesia as 
described in this study is widely utilized in many centers before this procedure.
CONCLUSIONS
Pre-induction hemodynamic assessment of MS using the Gorlin formula correlates 
well with echocardiographic measurements of MVA and trans-valvular gradients. Large 
variability in trans-mitral gradient and smaller yet significant over-estimation of valve area 
was observed after induction of anesthesia. 
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Figure 1. Total change in mitral valve gradient before and after anesthesia induction.
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p = 0.15
Figure 2. Total change in mitral valve area before and after anesthesia induction.
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Mitral Valve Area (Cm2) p = 0.01
Figure 3. Mean change in mitral valve gradient before and after anesthesia induction.
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Figure 4. Mean change in mitral valve area before and after anesthesia induction.
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Table 1. Baseline clinical and pre-procedural echocardiographic characteristics.
All data presented as mean ± standard deviation unless stated otherwise; AV — aortic valve; 
GFR — glomerular filtration rate; LA — left atrium; LV — left ventricle, MVA — mitral 
valve area; NYHA — New York Heart Association classification; TV — tricuspid valve
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0.7 ± 0.2Creatinine 





60.4 ± 3.2Left ventricular ejection fraction [%]
30 ± 6.8LA area [cm2]
4.8 ± 1.1LA diameter [cm]
128.3 ± 20LV mass [g]
9.8 ± 4.6Mean mitral gradient [mmHg]
18.9 ± 8.87Peak mitral gradient [mmHg]
1 ± 0.2MVA by planimetry [cm2]
1.1 ± 0.3MVA by pressure half time [cm2]
0.9 ± 0.3MVA by continuity [cm2]
6.5 ± 1.5Wilkins score
7.1%AV disease > mild
28.6%TV disease > mild
50.6 ± 17.3Systolic pulmonary artery pressure





0.265.2 (4.0–6.1)4.0 (3.1–5.7)Cardiac output
0.112.9 (2.4–3.9)2.0 (1.7–3.2)Cardiac index
0.1260 (56–66)86 (82–97)Aorta mean pressure
0.1285 (76–88)112 (104–126)Aorta systolic pressure 
0.0395 (83–106)126.0 (113–132)Left ventricular systolic 
pressure 0.1726 (22–33)30 (26–34)Mean pulmonary artery 
pressure 0.1119 (16–25)22 (19–27)Mean wedge pressure
0.1510.5 (7.2–15.5)13.0 (10.0–20.2)Mean mitral valve gradient
0.011.4 (1.0–1.5)1.0 (0.9–1.3)Mitral valve area 
0.061.2 (1.0–1.7)1.7 (1.0–2.8)Pulmonary vascular 
resistance 0.1512.5 (9.0–17.0)20.5 (14.2–30.5)Systemic vascular 
resistance 
